Heritage Investment Group’s West Pharmaceutical WST Stock Holding History

Heritage Investment Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Hold	3,372	–	–	0.16%	45
2026 Q1	$845K	Hold	3,372	–	–	0.13%	54
2025 Q4	$928K	Buy	3,372 +1	+0%	+$274	0.14%	49
2025 Q3	$884K	Hold	3,371	–	–	0.14%	47
2025 Q2	$738K	Hold	3,371	–	–	0.13%	50
2025 Q1	$755K	Hold	3,371	–	–	0.14%	48
2024 Q4	$1.1M	Hold	3,371	–	–	0.21%	36
2024 Q3	$1.01M	Hold	3,371	–	–	0.19%	35
2024 Q2	$1.11M	Hold	3,371	–	–	0.23%	32
2024 Q1	$1.33M	Hold	3,371	–	–	0.27%	30
2023 Q4	$1.19M	Hold	3,371	–	–	0.26%	31
2023 Q3	$1.26M	Hold	3,371	–	–	0.35%	26
2023 Q2	$1.29M	Hold	3,371	–	–	0.36%	23
2023 Q1	$1.17M	Hold	3,371	–	–	0.35%	20
2022 Q4	$793K	Hold	3,371	–	–	0.25%	29
2022 Q3	$830K	Sell	3,371 -29	-0.9%	-$8.84K	0.51%	23
2022 Q2	$1.03M	Hold	3,400	–	–	0.59%	22
2022 Q1	$1.4M	Hold	3,400	–	–	1.01%	13
2021 Q4	$1.59M	Buy	+3,400	New	+$1.46M	1.26%	12

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Heritage Investment Group's WST Position: Q2 2026 in Review

Heritage Investment Group held its West Pharmaceutical (WST) position steady in Q2 2026 at 3,372 shares worth $1.21M. The position accounts for 0.16% of the portfolio, ranked #45.

Heritage Investment Group first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.59M in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Heritage Investment Group held 3,372 shares of West Pharmaceutical worth $1.21M as of Q2 2026.
Heritage Investment Group left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.16% of Heritage Investment Group's portfolio in Q2 2026, its #45 holding.
Heritage Investment Group first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
Heritage Investment Group's West Pharmaceutical position peaked at $1.59M in Q4 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Heritage Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.